LUNG TRANSPLANT REJECTION
Clinical trials for LUNG TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled drug shows promise for lung transplant patients with chronic rejection
Disease control CompletedThis study tested an inhaled form of cyclosporine A (a drug that suppresses the immune system) added to standard care for people who had a single lung transplant and developed chronic lung rejection. The goal was to see if the drug could improve lung function over 48 weeks. The t…
Matched conditions: LUNG TRANSPLANT REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
Inhaled drug shows promise for lung transplant rejection in phase 3 trial
Disease control CompletedThis study tested whether adding an inhaled form of cyclosporine A (L-CsA) to standard treatment helps people who have chronic lung rejection after a double lung transplant. The trial included 169 adults who had their transplant at least a year earlier. The main goal was to see i…
Matched conditions: LUNG TRANSPLANT REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated May 17, 2026 02:38 UTC